Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 41

1.

Losing Control: Excessive Alcohol Seeking after Selective Inactivation of Cue-Responsive Neurons in the Infralimbic Cortex.

Pfarr S, Meinhardt MW, Klee ML, Hansson AC, Vengeliene V, Schönig K, Bartsch D, Hope BT, Spanagel R, Sommer WH.

J Neurosci. 2015 Jul 29;35(30):10750-61. doi: 10.1523/JNEUROSCI.0684-15.2015.

PMID:
26224858
2.

Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III.

Björkqvist J, de Maat S, Lewandrowski U, Di Gennaro A, Oschatz C, Schönig K, Nöthen MM, Drouet C, Braley H, Nolte MW, Sickmann A, Panousis C, Maas C, Renné T.

J Clin Invest. 2015 Aug 3;125(8):3132-46. doi: 10.1172/JCI77139. Epub 2015 Jul 20.

PMID:
26193639
3.

A Limited Role for the Cell Cycle Regulator Cyclin A1 in Murine Leukemogenesis.

Bäumer N, Bäumer S, Haak M, Koschmieder S, Schönig K, Berdel WE, Müller-Tidow C.

PLoS One. 2015 Jun 16;10(6):e0129147. doi: 10.1371/journal.pone.0129147. eCollection 2015.

4.

γ-Aminobutyric A receptor (GABA(A)R) regulates aquaporin 4 expression in the subependymal zone: relevance to neural precursors and water exchange.

Li Y, Schmidt-Edelkraut U, Poetz F, Oliva I, Mandl C, Hölzl-Wenig G, Schönig K, Bartsch D, Ciccolini F.

J Biol Chem. 2015 Feb 13;290(7):4343-55. doi: 10.1074/jbc.M114.618686. Epub 2014 Dec 24.

PMID:
25540202
5.

Postnatal subventricular zone progenitors switch their fate to generate neurons with distinct synaptic input patterns.

Ravi N, Li Z, Oettl LL, Bartsch D, Schönig K, Kelsch W.

Development. 2015 Jan 15;142(2):303-13. doi: 10.1242/dev.110767. Epub 2014 Dec 17.

6.

Global increase of p16INK4a in APC-deficient mouse liver drives clonal growth of p16INK4a-negative tumors.

Ueberham E, Glöckner P, Göhler C, Straub BK, Teupser D, Schönig K, Braeuning A, Höhn AK, Jerchow B, Birchmeier W, Gaunitz F, Arendt T, Sansom O, Gebhardt R, Ueberham U.

Mol Cancer Res. 2015 Feb;13(2):239-49. doi: 10.1158/1541-7786.MCR-14-0278-T. Epub 2014 Sep 30.

PMID:
25270420
7.

Nogo-A-deficient Transgenic Rats Show Deficits in Higher Cognitive Functions, Decreased Anxiety, and Altered Circadian Activity Patterns.

Petrasek T, Prokopova I, Sladek M, Weissova K, Vojtechova I, Bahnik S, Zemanova A, Schönig K, Berger S, Tews B, Bartsch D, Schwab ME, Sumova A, Stuchlik A.

Front Behav Neurosci. 2014 Mar 18;8:90. doi: 10.3389/fnbeh.2014.00090. eCollection 2014.

8.

Reduced expression of nogo-a leads to motivational deficits in rats.

Enkel T, Berger SM, Schönig K, Tews B, Bartsch D.

Front Behav Neurosci. 2014 Jan 22;8:10. doi: 10.3389/fnbeh.2014.00010. eCollection 2014.

9.

Nogo-A downregulation impairs place avoidance in the Carousel maze but not spatial memory in the Morris water maze.

Petrasek T, Prokopova I, Bahnik S, Schonig K, Berger S, Vales K, Tews B, Schwab ME, Bartsch D, Stuchlik A.

Neurobiol Learn Mem. 2014 Jan;107:42-9. doi: 10.1016/j.nlm.2013.10.015. Epub 2013 Nov 6.

PMID:
24211256
10.

N-Methyl-d-Aspartate Receptor - Nitric Oxide Synthase Pathway in the Cortex of Nogo-A-Deficient Rats in Relation to Brain Laterality and Schizophrenia.

Krištofiková Z, Vrajová M, Sírová J, Valeš K, Petrásek T, Schönig K, Tews B, Schwab M, Bartsch D, Stuchlík A, Rípová D.

Front Behav Neurosci. 2013 Aug 12;7:90. doi: 10.3389/fnbeh.2013.00090. eCollection 2013.

11.

Synthetic microRNA-mediated downregulation of Nogo-A in transgenic rats reveals its role as regulator of synaptic plasticity and cognitive function.

Tews B, Schönig K, Arzt ME, Clementi S, Rioult-Pedotti MS, Zemmar A, Berger SM, Schneider M, Enkel T, Weinmann O, Kasper H, Schwab ME, Bartsch D.

Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):6583-8. doi: 10.1073/pnas.1217665110. Epub 2013 Apr 1.

12.

Transforming growth factor beta receptor 2 (TGFBR2) changes sialylation in the microsatellite unstable (MSI) Colorectal cancer cell line HCT116.

Lee J, Ballikaya S, Schönig K, Ball CR, Glimm H, Kopitz J, Gebert J.

PLoS One. 2013;8(2):e57074. doi: 10.1371/journal.pone.0057074. Epub 2013 Feb 27.

13.

A progressive dopaminergic phenotype associated with neurotoxic conversion of α-synuclein in BAC-transgenic rats.

Nuber S, Harmuth F, Kohl Z, Adame A, Trejo M, Schönig K, Zimmermann F, Bauer C, Casadei N, Giel C, Calaminus C, Pichler BJ, Jensen PH, Müller CP, Amato D, Kornhuber J, Teismann P, Yamakado H, Takahashi R, Winkler J, Masliah E, Riess O.

Brain. 2013 Feb;136(Pt 2):412-32. doi: 10.1093/brain/aws358.

14.

Tet-Transgenic Rodents: a comprehensive, up-to date database.

Schönig K, Freundlieb S, Gossen M.

Transgenic Res. 2013 Apr;22(2):251-4. doi: 10.1007/s11248-012-9660-9. Epub 2012 Nov 23.

15.

Conditional gene expression systems in the transgenic rat brain.

Schönig K, Weber T, Frömmig A, Wendler L, Pesold B, Djandji D, Bujard H, Bartsch D.

BMC Biol. 2012 Sep 3;10:77. doi: 10.1186/1741-7007-10-77.

16.

Srgap3⁻/⁻ mice present a neurodevelopmental disorder with schizophrenia-related intermediate phenotypes.

Waltereit R, Leimer U, von Bohlen Und Halbach O, Panke J, Hölter SM, Garrett L, Wittig K, Schneider M, Schmitt C, Calzada-Wack J, Neff F, Becker L, Prehn C, Kutscherjawy S, Endris V, Bacon C, Fuchs H, Gailus-Durner V, Berger S, Schönig K, Adamski J, Klopstock T, Esposito I, Wurst W, de Angelis MH, Rappold G, Wieland T, Bartsch D.

FASEB J. 2012 Nov;26(11):4418-28. doi: 10.1096/fj.11-202317. Epub 2012 Jul 20.

17.

Tetracycline inducible gene manipulation in serotonergic neurons.

Weber T, Renzland I, Baur M, Mönks S, Herrmann E, Huppert V, Nürnberg F, Schönig K, Bartsch D.

PLoS One. 2012;7(5):e38193. doi: 10.1371/journal.pone.0038193. Epub 2012 May 31.

18.

Retrocochlear function of the peripheral deafness gene Cacna1d.

Satheesh SV, Kunert K, Rüttiger L, Zuccotti A, Schönig K, Friauf E, Knipper M, Bartsch D, Nothwang HG.

Hum Mol Genet. 2012 Sep 1;21(17):3896-909. doi: 10.1093/hmg/dds217. Epub 2012 Jun 7.

19.

Inducible gene manipulations in brain serotonergic neurons of transgenic rats.

Weber T, Schönig K, Tews B, Bartsch D.

PLoS One. 2011;6(11):e28283. doi: 10.1371/journal.pone.0028283. Epub 2011 Nov 29.

20.

The power of reversibility regulating gene activities via tetracycline-controlled transcription.

Schönig K, Bujard H, Gossen M.

Methods Enzymol. 2010;477:429-53. doi: 10.1016/S0076-6879(10)77022-1.

PMID:
20699154
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk